Neutrophils as emerging therapeutic targets

T Németh, M Sperandio, A Mócsai - Nature reviews Drug discovery, 2020 - nature.com
Neutrophils are the most abundant circulating leukocytes, being the first line of defence
against bacterial and fungal infections. However, neutrophils also contribute to tissue …

Host–microbiota interactions in immune-mediated diseases

WE Ruff, TM Greiling, MA Kriegel - Nature Reviews Microbiology, 2020 - nature.com
Host–microbiota interactions are fundamental for the development of the immune system.
Drastic changes in modern environments and lifestyles have led to an imbalance of this …

[HTML][HTML] Ruxolitinib for glucocorticoid-refractory chronic graft-versus-host disease

R Zeiser, N Polverelli, R Ram, SK Hashmi… - … England Journal of …, 2021 - Mass Medical Soc
Background Chronic graft-versus-host disease (GVHD), a major complication of allogeneic
stem-cell transplantation, becomes glucocorticoid-refractory or glucocorticoid-dependent in …

Ruxolitinib for glucocorticoid-refractory acute graft-versus-host disease

R Zeiser, N von Bubnoff, J Butler, M Mohty… - … England Journal of …, 2020 - Mass Medical Soc
Background Acute graft-versus-host disease (GVHD) remains a major limitation of
allogeneic stem-cell transplantation; not all patients have a response to standard …

Acute graft-versus-host disease—biologic process, prevention, and therapy

R Zeiser, BR Blazar - New England Journal of Medicine, 2017 - Mass Medical Soc
When T cells from a bone marrow donor begin to attack the host within 3 months after
hematopoietic-cell transplantation, acute graft-versus-host disease results. The disease …

Pathophysiology of chronic graft-versus-host disease and therapeutic targets

R Zeiser, BR Blazar - New England Journal of Medicine, 2017 - Mass Medical Soc
Chronic GVHD, an autoimmune disease that follows allogeneic hematopoietic-cell
transplantation, is characterized by infections and debilitating tissue injury leading to …

The microbiome and innate immunity

CA Thaiss, N Zmora, M Levy, E Elinav - Nature, 2016 - nature.com
The intestinal microbiome is a signalling hub that integrates environmental inputs, such as
diet, with genetic and immune signals to affect the host's metabolism, immunity and …

Endogenous non-enzymatic antioxidants in the human body

I Mirończuk-Chodakowska, AM Witkowska… - Advances in medical …, 2018 - Elsevier
The exposure of cells, tissues and extracellular matrix to harmful reactive species causes a
cascade of reactions and induces activation of multiple internal defence mechanisms …

Gut microbiome and aging: Physiological and mechanistic insights

R Nagpal, R Mainali, S Ahmadi, S Wang… - … and healthy aging, 2018 - content.iospress.com
The development of human gut microbiota begins as soon as the neonate leaves the
protective environment of the uterus (or maybe in-utero) and is exposed to innumerable …

Increased GVHD-related mortality with broad-spectrum antibiotic use after allogeneic hematopoietic stem cell transplantation in human patients and mice

Y Shono, MD Docampo, JU Peled… - Science translational …, 2016 - science.org
Intestinal bacteria may modulate the risk of infection and graft-versus-host disease (GVHD)
after allogeneic hematopoietic stem cell transplantation (allo-HSCT). Allo-HSCT recipients …